HMC Council forum focuses on ‘post-Vioxx’ marketing

Share this article:

The HMC Council's Industry Forum upcoming event titled
"Communicating Risk Information on Prescription Drugs in the Post-Vioxx Environment," will take place on March 16 at the Glenpointe Marriott in Teaneck, N.J. Wayne Pines of APCO will serve as the moderator of a panel of experts. A calendar listing in the February issue of MM&M misidentified subject matter of the event.

Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...